86.10.0
SHIFOXONА MUАSSАSАLАRI FАOLIYATI
110
XUSUSIY KORXONA
79994
Davlat va xo'jalik boshqaruvi organlari tarkibiga kirmagan tadbirkorlik sub'ektlari
1708401
Республика Узбекистан, Джизакская область, Джизак
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on arbitration cases
No data on participation in public procurement as a supplier or customer
Коротко о компании
DOKTOR ABBOS-DOSTON has been operating since 2009 in the "Деятельность больничных учреждений" industry. The director is ZAKIROV IKROM DAVRANOVICH. The company belongs to the "Microcompany" category. Its primary activity is "Деятельность больничных учреждений". The company has 1 founders, one of whom owns a 100% stake. The company has 2 licenses, confirming the broad scope of permitted activities in "Деятельность больничных учреждений".. The company holds property totaling 1 units, is included in 0, and has 162 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
No data on related organizations
No data on trademarks
Коротко о компании
DOKTOR ABBOS-DOSTON has been operating since 2009 in the "Деятельность больничных учреждений" industry. The director is ZAKIROV IKROM DAVRANOVICH. The company belongs to the "Microcompany" category. Its primary activity is "Деятельность больничных учреждений". The company has 1 founders, one of whom owns a 100% stake. The company has 2 licenses, confirming the broad scope of permitted activities in "Деятельность больничных учреждений".. The company holds property totaling 1 units, is included in 0, and has 162 similar companies, indicating a developed competitive market.